![MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040423083/2053914361/gr1.jpg)
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology
![MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0759-9/MediaObjects/13045_2019_759_Fig2_HTML.png)
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
![Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib - Lung Cancer Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a7ae8263-30bc-4e09-b962-f3817bf795d7/gr1_lrg.jpg)
Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib - Lung Cancer
PLOS ONE: MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population
![c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram](https://www.researchgate.net/publication/337401900/figure/fig5/AS:963238208475137@1606665293040/c-MET-amplification-upregulated-PD-L1-expression-in-EGFR-TKIresistant-NSCLC-cells-a.png)
c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram
![Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer? - ScienceDirect Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737217301597-gr1.jpg)
Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer? - ScienceDirect
![A Survey of c-MET Expression and Amplification in 287 Patients with Hepatocellular Carcinoma | Anticancer Research A Survey of c-MET Expression and Amplification in 287 Patients with Hepatocellular Carcinoma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/11/5179/F3.large.jpg)
A Survey of c-MET Expression and Amplification in 287 Patients with Hepatocellular Carcinoma | Anticancer Research
![MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0759-9/MediaObjects/13045_2019_759_Fig3_HTML.png)